Israel - Inggeris - Ministry of Health

eli lilly israel ltd - prasugrel as hydrochloride - film coated tablets - prasugrel as hydrochloride 10 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci). the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 or weight below 60 kg.

Afrika Selatan - Inggeris - South African Health Products Regulatory Authority (SAHPRA)

eli lilly (s.a.) (pty) ltd - infusion (parenteral) - see ingredients - each vial contains pemetrexed sodium 100,0 mg

Afrika Selatan - Inggeris - South African Health Products Regulatory Authority (SAHPRA)

eli lilly (s.a.) (pty) ltd - infusion (parenteral) - see ingredients - each vial contains pemetrexed sodium 500,0 mg

Afrika Selatan - Inggeris - South African Health Products Regulatory Authority (SAHPRA)

eli lilly (s.a.) (pty) ltd - infusion (parenteral) - see ingredients - each 10,0 ml solution contains ramucirumab 100,0 mg

Afrika Selatan - Inggeris - South African Health Products Regulatory Authority (SAHPRA)

eli lilly (s.a.) (pty) ltd - infusion (parenteral) - see ingredients - each 10,0 ml solution contains ramucirumab 500,0 mg

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

eli lilly nederland b.v. - drotrecogin alfa (activated) - sepsis; multiple organ failure - antithrombotic agents - xigris is indicated for the treatment of adult patients with severe sepsis with multiple organ failure when added to best standard care. the use of xigris should be considered mainly in situations when therapy can be started within 24 hours after the onset of organ failure (for further information see section 5.1).

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

eli lilly and company ltd - insulin soluble human - solution for injection - 100unit/1ml

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

eli lilly and company ltd - insulin isophane human - suspension for injection - 100unit/1ml

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

eli lilly and company ltd - insulin soluble human; insulin isophane human - suspension for injection - 30unit/1ml ; 70unit/1ml

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

eli lilly nederland b.v. - duloxetine - diabetic neuropathies - psychoanaleptics, - treatment of diabetic peripheral neuropathic pain.ariclaim is indicated in adults.